long term side effects of glp-1 receptor agonists Adverse Safety and Tolerability of Glucagon-Like

Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial

The combination of improved blood pressure with a modest heart rate increase represents a net cardiovascular benefit for most individuals, but monitoring remains essential for those with pre-existing conditions

Who Should Be Careful With Weight Loss Medications

In the late stages of PD, the key molecular pathogenic mechanisms include the misfolding and aggregation of -synuclein, mitochondrial dysfunction, impaired protein clearance (related to inefficient ubiquitin-proteasome and autophagy-lysosomal systems), neuroinflammation and oxidative stress (57)

Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: Mechanistic insights and therapeutic implications